193 related articles for article (PubMed ID: 33282746)
1. The Risk of Second Primary Cancers in Prostate Cancer Survivors Treated in the Modern Radiotherapy Era.
Jahreiß MC; Aben KKH; Hoogeman MS; Dirkx MLP; de Vries KC; Incrocci L; Heemsbergen WD
Front Oncol; 2020; 10():605119. PubMed ID: 33282746
[TBL] [Abstract][Full Text] [Related]
2. Impact of Advanced Radiotherapy on Second Primary Cancer Risk in Prostate Cancer Survivors: A Nationwide Cohort Study.
Jahreiß MC; Heemsbergen WD; van Santvoort B; Hoogeman M; Dirkx M; Pos FJ; Janssen T; Dekker A; Vanneste B; Minken A; Hoekstra C; Smeenk RJ; van Oort IM; Bangma CH; Incrocci L; Aben KKH
Front Oncol; 2021; 11():771956. PubMed ID: 34900722
[TBL] [Abstract][Full Text] [Related]
3. Comparing Risk for Second Primary Cancers After Intensity-Modulated vs 3-Dimensional Conformal Radiation Therapy for Prostate Cancer, 2002-2015.
Pithadia KJ; Advani PG; Citrin DE; Bekelman JE; Withrow DR; Berrington de Gonzalez A; Morton LM; Schonfeld SJ
JAMA Oncol; 2023 Aug; 9(8):1119-1123. PubMed ID: 37289449
[TBL] [Abstract][Full Text] [Related]
4. Second primary cancer after intensity-modulated radiotherapy for nasopharyngeal carcinoma: A territory-wide study by HKNPCSG.
Chow JCH; Tam AHP; Cheung KM; Lee VHF; Chiang CL; Tong M; Wong ECY; Cheung AKW; Chan SPC; Lai JWY; Ngan RKC; Ng WT; Lee AWM; Au KH
Oral Oncol; 2020 Dec; 111():105012. PubMed ID: 32980659
[TBL] [Abstract][Full Text] [Related]
5. Advances in radiotherapy and its impact on second primary cancer risk: A multi-center cohort study in prostate cancer patients.
Jahreiß MC; Hoogeman M; Aben KK; Dirkx M; Snieders R; Pos FJ; Janssen T; Dekker A; Vanneste B; Minken A; Hoekstra C; Smeenk RJ; Incrocci L; Heemsbergen WD
Radiother Oncol; 2023 Jun; 183():109659. PubMed ID: 37003369
[TBL] [Abstract][Full Text] [Related]
6. Impact of Advanced External Beam Radiotherapy on Second Haematological Cancer Risk in Prostate Cancer Survivors.
Jahreiß MC; Heemsbergen WD; Janus C; van de Pol M; Dirkx M; Dinmohamed AG; Nout RA; Hoogeman M; Incrocci L; Aben KKH
Clin Oncol (R Coll Radiol); 2023 Apr; 35(4):e278-e288. PubMed ID: 36725405
[TBL] [Abstract][Full Text] [Related]
7. Incidence of second primary cancers among survivors of childhood cancer: A population-based study, Osaka, Japan, 1975-2015.
Odani S; Nakata K; Inoue M; Kato M; Saito MK; Morishima T; Hashii Y; Hara J; Kawa K; Miyashiro I
Cancer Sci; 2023 Mar; 114(3):1142-1153. PubMed ID: 36345911
[TBL] [Abstract][Full Text] [Related]
8. Second cancer risk after primary cancer treatment with three-dimensional conformal, intensity-modulated, or proton beam radiation therapy.
Xiang M; Chang DT; Pollom EL
Cancer; 2020 Aug; 126(15):3560-3568. PubMed ID: 32426866
[TBL] [Abstract][Full Text] [Related]
9. Significant risk of second primary cancer among laryngeal squamous cell carcinoma patients even after 20 years.
Nikkilä R; Hirvonen E; Haapaniemi A; Tapiovaara L; Pitkäniemi J; Malila N; Mäkitie A
Acta Oncol; 2023 Oct; 62(10):1322-1330. PubMed ID: 37672344
[TBL] [Abstract][Full Text] [Related]
10. Association of First Primary Cancer With Risk of Subsequent Primary Cancer Among Survivors of Adult-Onset Cancers in the United States.
Sung H; Hyun N; Leach CR; Yabroff KR; Jemal A
JAMA; 2020 Dec; 324(24):2521-2535. PubMed ID: 33351041
[TBL] [Abstract][Full Text] [Related]
11. Second cancer risk in childhood cancer survivors treated with intensity-modulated radiation therapy (IMRT).
Casey DL; Friedman DN; Moskowitz CS; Hilden PD; Sklar CA; Wexler LH; Wolden SL
Pediatr Blood Cancer; 2015 Feb; 62(2):311-316. PubMed ID: 25328040
[TBL] [Abstract][Full Text] [Related]
12. Intensity-Modulated Radiation Therapy May Improve Local-Regional Tumor Control for Locally Advanced Non-Small Cell Lung Cancer Compared With Three-Dimensional Conformal Radiation Therapy.
Wang J; Zhou Z; Liang J; Feng Q; Xiao Z; Hui Z; Wang X; Lv J; Chen D; Zhang H; Ji Z; Cao J; Liu L; Jiang W; Men Y; Xu C; Dai J; Yin W; Wang L
Oncologist; 2016 Dec; 21(12):1530-1537. PubMed ID: 27628491
[TBL] [Abstract][Full Text] [Related]
13. Intensity-modulated radiotherapy improves lymph node coverage and dose to critical structures compared with three-dimensional conformal radiation therapy in clinically localized prostate cancer.
Wang-Chesebro A; Xia P; Coleman J; Akazawa C; Roach M
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):654-62. PubMed ID: 17011444
[TBL] [Abstract][Full Text] [Related]
14. Risk of Subsequent Primary Cancers Among Adult-Onset 5-Year Cancer Survivors in South Korea: Retrospective Cohort Study.
Choi YY; Lee M; Kim EH; Lee JE; Jung I; Cheong JH
JMIR Public Health Surveill; 2024 May; 10():e48380. PubMed ID: 38717807
[TBL] [Abstract][Full Text] [Related]
15. Second cancer risk in childhood cancer survivors treated with intensity-modulated radiation therapy: An updated analysis of more than 10 years of follow-up.
Tringale KR; Casey DL; Niyazov G; Lavery JA; Moskowitz C; Friedman DN; Wolden SL
Pediatr Blood Cancer; 2022 May; 69(5):e29600. PubMed ID: 35234340
[TBL] [Abstract][Full Text] [Related]
16. Intensity-modulated radiotherapy for the treatment of prostate cancer: a systematic review and economic evaluation.
Hummel S; Simpson EL; Hemingway P; Stevenson MD; Rees A
Health Technol Assess; 2010 Oct; 14(47):1-108, iii-iv. PubMed ID: 21029717
[TBL] [Abstract][Full Text] [Related]
17. A comparison of clinical outcomes between three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for prostate cancer.
Shimizuguchi T; Nihei K; Okano T; Machitori Y; Ito K; Karasawa K
Int J Clin Oncol; 2017 Apr; 22(2):373-379. PubMed ID: 27778117
[TBL] [Abstract][Full Text] [Related]
18. Radiation-induced second primary cancer risks from modern external beam radiotherapy for early prostate cancer: impact of stereotactic ablative radiotherapy (SABR), volumetric modulated arc therapy (VMAT) and flattening filter free (FFF) radiotherapy.
Murray LJ; Thompson CM; Lilley J; Cosgrove V; Franks K; Sebag-Montefiore D; Henry AM
Phys Med Biol; 2015 Feb; 60(3):1237-57. PubMed ID: 25590229
[TBL] [Abstract][Full Text] [Related]
19. Second primary cancer among 217702 colorectal cancer survivors: An analysis of national German cancer registry data.
Liang LA; Tseng YJ; Tanaka LF; Klug SJ
Int J Cancer; 2023 Oct; 153(8):1459-1471. PubMed ID: 37392091
[TBL] [Abstract][Full Text] [Related]
20. Improvement in toxicity in high risk prostate cancer patients treated with image-guided intensity-modulated radiotherapy compared to 3D conformal radiotherapy without daily image guidance.
Sveistrup J; af Rosenschöld PM; Deasy JO; Oh JH; Pommer T; Petersen PM; Engelholm SA
Radiat Oncol; 2014 Feb; 9():44. PubMed ID: 24495815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
